- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/30 - Nitrogen atoms non-acylated
Patent holdings for IPC class C07D 295/30
Total number of patents in this class: 33
10-year publication summary
|
5
|
3
|
2
|
0
|
1
|
0
|
1
|
3
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Axolabs GmbH | 14 |
4 |
| The Trustees of Columbia University in the City of New York | 3643 |
3 |
| Abbvie Inc. | 1836 |
3 |
| Sutter Bay Hospitals | 17 |
3 |
| Centre National de La Recherche Scientifique | 11016 |
2 |
| St. Mary's University | 9 |
2 |
| Universite de Montpellier | 1042 |
2 |
| Janssen Pharmaceutica N.V. | 3171 |
1 |
| Arizona Board of Regents on behalf of Arizona State University | 2930 |
1 |
| Axsome Therapeutics, Inc. | 382 |
1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 774 |
1 |
| Innovascreen Inc. | 4 |
1 |
| Pharmos Corporation | 1 |
1 |
| Reuter Chemische Apparatebau KG | 15 |
1 |
| Suven Life Sciences Limited | 138 |
1 |
| Synta Pharmaceuticals Corp. | 146 |
1 |
| The United States Government AS represented by The Department of Veterans Affairs | 1326 |
1 |
| University of Memphis Research Foundation | 123 |
1 |
| University of Tennessee Research Foundation | 758 |
1 |
| The Walter and Eliza Hall Institute of Medical Research | 166 |
1 |
| Other owners | 1 |